|
| 促红细胞生成素在心血管手术中应用的研究进展 |
| Research progress of erythropoietin in patients undergoing cardiovascular surgery |
| |
| DOI：10.12089/jca.2023.01.018 |
| 中文关键词: 促红细胞生成素 心血管手术 异体输血 血液保护 |
| 英文关键词: Erythropoietin Cardiovascular surgery Allogeneic blood transfusion Blood protection |
| 基金项目:国家自然科学基金（81960669）；中国医学科学院临床与转化医学研究基金（2020-I2M-C＆T-B-063） |
|
| 摘要点击次数: 673 |
| 全文下载次数: 228 |
| 中文摘要: |
| 心血管手术患者具有病情危重、合并症多，异体输血率高等特点。在血制品供需不平衡的前提下，异体输血可增加患者术后并发症。促红细胞生成素在心血管手术围术期应用具有明显的优势，有望为心血管手术围术期患者提供更好的血液和器官保护管理。本文就促红细胞生成素在心血管手术围术期临床应用价值和局限性的最新进展进行综述，为临床医师在心血管手术围术期患者使用促红细胞生成素提供参考。 |
| 英文摘要: |
| Cardiovascular surgery patients have the characteristics of more critical disease, more comorbidities, and higher allogeneic blood transfusion rate. Under the premise of imbalance between supply and demand of blood products, allogeneic blood transfusion can increase the incidence of postoperative complications and economic burden in patients. In recent years, with the continuous exploration of the advantages of erythropoietin in the perioperative period of cardiovascular surgery, it is expected to provide better blood management for patients in the perioperative period of cardiovascular surgery. This paper reviews the recent advance in the clinical value and limitations of erythropoietin in the perioperative period of cardiovascular surgery and provides a reference for clinicians to use erythropoietin in the perioperative period of cardiovascular surgery. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
